Correlation Between Pure Cycle and MIRA Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both Pure Cycle and MIRA Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pure Cycle and MIRA Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pure Cycle and MIRA Pharmaceuticals, Common, you can compare the effects of market volatilities on Pure Cycle and MIRA Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pure Cycle with a short position of MIRA Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pure Cycle and MIRA Pharmaceuticals,.

Diversification Opportunities for Pure Cycle and MIRA Pharmaceuticals,

0.04

Correlation Coefficient

Pure Cycle  MIRA Pharmaceuticals,

Significant diversification

The 3 months correlation between Pure and MIRA is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Pure Cycle and MIRA Pharmaceuticals, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MIRA Pharmaceuticals, and Pure Cycle is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pure Cycle are associated (or correlated) with MIRA Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MIRA Pharmaceuticals, has no effect on the direction of Pure Cycle i.e., Pure Cycle and MIRA Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Pure Cycle and MIRA Pharmaceuticals,

Given the investment horizon of 90 days Pure Cycle is expected to generate 12.21 times less return on investment than MIRA Pharmaceuticals,. But when comparing it to its historical volatility, Pure Cycle is 19.83 times less risky than MIRA Pharmaceuticals,. It trades about 0.06 of its potential returns per unit of risk. MIRA Pharmaceuticals, Common is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  465.00  in MIRA Pharmaceuticals, Common on September 14, 2024 and sell it today you would lose (353.00) from holding MIRA Pharmaceuticals, Common or give up 75.91% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pure Cycle  vs.  MIRA Pharmaceuticals, Common

Pure Cycle

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Pure Cycle are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Pure Cycle displayed solid returns over the last few months and may actually be approaching a breakup point.

MIRA Pharmaceuticals,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MIRA Pharmaceuticals, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, MIRA Pharmaceuticals, is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Pure Cycle and MIRA Pharmaceuticals,

The main advantage of trading using opposite Pure Cycle and MIRA Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pure Cycle position performs unexpectedly, MIRA Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MIRA Pharmaceuticals, will offset losses from the drop in MIRA Pharmaceuticals,'s long position.

The idea behind Pure Cycle and MIRA Pharmaceuticals, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.